SEC62 and prostate carcinoma: The authors are grateful to their former colleague in Homburg Prof. Bernd Wullich (Department of Urology and Pediatric Urology, Erlangen University Medical Center, Erlangen, Germany) for drawing their attention to the overexpression of the SEC62 gene in prostate cancer, to Lars Kästner and Peter Lipp (both Saarland University) for the fluorescence micrograph in Figure 1, and to Stefan Pfeffer and Friedrich Förster (both formerly at the Max-Planck Institute of Biochemistry, Martinsried, Germany).